XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Total Revenues $ 4,258 $ 11,688 $ 8,377 $ 13,438
Cost of goods sold 795 216 1,396 487
Operating Expenses:        
Research and development 6,409 13,119 12,742 29,072
Selling, general and administrative 15,835 26,459 32,451 51,874
Goodwill and in-process research & development impairments 0 54,345 0 54,345
Contingent Stock Right Remeasurement 0 84,726 0 84,726
Total Operating Expenses 22,244 178,649 45,193 220,017
Operating Loss 18,781 167,177 38,212 207,066
Interest expense 1,074 1,070 2,136 2,137
Other expense (income), net 69 (548) 126 (1,271)
Loss Before Income Tax 19,924 167,699 40,474 207,932
Income tax expense (benefit) 0 (259) 0 (259)
Net Loss $ 19,924 $ 167,440 $ 40,474 $ 207,673
Loss per share basic (in dollars per share) $ 0.39 $ 4.83 $ 0.81 $ 9.17
Loss per share diluted (in dollars per share) $ 0.39 $ 4.83 $ 0.81 $ 9.17
Weighted average shares outstanding - basic (in shares) 51,411 34,663 50,162 22,656
Weighted average shares outstanding - diluted (in shares) 51,411 34,663 50,162 22,656
Product sales        
Total Revenues $ 3,963 $ 1,483 $ 7,852 $ 3,233
License revenues        
Total Revenues 0 10,000 0 10,000
Royalty revenues        
Total Revenues $ 295 $ 205 $ 525 $ 205